Maternal Serum Resistin Is Reduced in First Trimester Preeclampsia Pregnancies and Is a Marker of Clinical Severity

Michael Christiansen; Paula L Hedley; Sophie Placing; Karen R Wøjdemann; Anting L Carlsen; Jennifer Maureen Jørgensen; Anne Cathrine Gjerris; Anne-Cathrine Shalmi; Line Rode; Karin Sundberg; Ann Tabor

doi:10.3109/10641955.2014.913615

Maternal Serum Resistin Is Reduced in First Trimester Preeclampsia Pregnancies and Is a Marker of Clinical Severity

Michael Christiansen, Paula L Hedley, Sophie Placing, Karen R Wøjdemann, Anting L Carlsen, Jennifer Maureen Jørgensen, Anne Cathrine Gjerris, Anne-Cathrine Shalmi, Line Rode, Karin Sundberg, Ann Tabor

Gynækologisk og Obstetrisk Afd.

12 Citationer (Scopus)

Abstract

OBJECTIVE: To examine whether resistin levels in first trimester maternal serum are associated with insulin resistance or preeclampsia (PE).

METHODS: A case-control study of maternal serum resistin concentration conducted using 285 normal pregnancies and 123 PE pregnancies matched for gestational age, parity and maternal age. Samples were taken in gestational weeks 10(+0)-13(+6).

RESULTS: There was a negative correlation between resistin and clinical severity of PE, but no correlation with IS, TNF-α, body mass index, birth weight and pregnancy length.

CONCLUSIONS: Resistin is reduced in first trimester of PE pregnancies, particularly in severe PE. Inflammation and IS cannot explain this phenomenon.

Originalsprog	Engelsk
Tidsskrift	Hypertension in Pregnancy
Vol/bind	34
Udgave nummer	4
Sider (fra-til)	422-433
ISSN	1064-1955
DOI	https://doi.org/10.3109/10641955.2014.913615
Status	Udgivet - 4 dec. 2015

Adgang til dokumentet

10.3109/10641955.2014.913615

Citationsformater

Christiansen, M., Hedley, P. L., Placing, S., Wøjdemann, K. R., Carlsen, A. L., Jørgensen, J. M., Gjerris, A. C., Shalmi, A.-C., Rode, L., Sundberg, K., & Tabor, A. (2015). Maternal Serum Resistin Is Reduced in First Trimester Preeclampsia Pregnancies and Is a Marker of Clinical Severity. Hypertension in Pregnancy, 34(4), 422-433. https://doi.org/10.3109/10641955.2014.913615

@article{21474ba973b841749a44df5caf2dfcda,

title = "Maternal Serum Resistin Is Reduced in First Trimester Preeclampsia Pregnancies and Is a Marker of Clinical Severity",

abstract = "OBJECTIVE: To examine whether resistin levels in first trimester maternal serum are associated with insulin resistance or preeclampsia (PE).METHODS: A case-control study of maternal serum resistin concentration conducted using 285 normal pregnancies and 123 PE pregnancies matched for gestational age, parity and maternal age. Samples were taken in gestational weeks 10(+0)-13(+6).RESULTS: There was a negative correlation between resistin and clinical severity of PE, but no correlation with IS, TNF-α, body mass index, birth weight and pregnancy length.CONCLUSIONS: Resistin is reduced in first trimester of PE pregnancies, particularly in severe PE. Inflammation and IS cannot explain this phenomenon.",

author = "Michael Christiansen and Hedley, {Paula L} and Sophie Placing and W{\o}jdemann, {Karen R} and Carlsen, {Anting L} and J{\o}rgensen, {Jennifer Maureen} and Gjerris, {Anne Cathrine} and Anne-Cathrine Shalmi and Line Rode and Karin Sundberg and Ann Tabor",

year = "2015",

month = dec,

day = "4",

doi = "10.3109/10641955.2014.913615",

language = "English",

volume = "34",

pages = "422--433",

journal = "Hypertension in Pregnancy",

issn = "1064-1955",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Maternal Serum Resistin Is Reduced in First Trimester Preeclampsia Pregnancies and Is a Marker of Clinical Severity

AU - Christiansen, Michael

AU - Hedley, Paula L

AU - Placing, Sophie

AU - Wøjdemann, Karen R

AU - Carlsen, Anting L

AU - Jørgensen, Jennifer Maureen

AU - Gjerris, Anne Cathrine

AU - Shalmi, Anne-Cathrine

AU - Rode, Line

AU - Sundberg, Karin

AU - Tabor, Ann

PY - 2015/12/4

Y1 - 2015/12/4

N2 - OBJECTIVE: To examine whether resistin levels in first trimester maternal serum are associated with insulin resistance or preeclampsia (PE).METHODS: A case-control study of maternal serum resistin concentration conducted using 285 normal pregnancies and 123 PE pregnancies matched for gestational age, parity and maternal age. Samples were taken in gestational weeks 10(+0)-13(+6).RESULTS: There was a negative correlation between resistin and clinical severity of PE, but no correlation with IS, TNF-α, body mass index, birth weight and pregnancy length.CONCLUSIONS: Resistin is reduced in first trimester of PE pregnancies, particularly in severe PE. Inflammation and IS cannot explain this phenomenon.

AB - OBJECTIVE: To examine whether resistin levels in first trimester maternal serum are associated with insulin resistance or preeclampsia (PE).METHODS: A case-control study of maternal serum resistin concentration conducted using 285 normal pregnancies and 123 PE pregnancies matched for gestational age, parity and maternal age. Samples were taken in gestational weeks 10(+0)-13(+6).RESULTS: There was a negative correlation between resistin and clinical severity of PE, but no correlation with IS, TNF-α, body mass index, birth weight and pregnancy length.CONCLUSIONS: Resistin is reduced in first trimester of PE pregnancies, particularly in severe PE. Inflammation and IS cannot explain this phenomenon.

U2 - 10.3109/10641955.2014.913615

DO - 10.3109/10641955.2014.913615

M3 - Journal article

C2 - 26636480

SN - 1064-1955

VL - 34

SP - 422

EP - 433

JO - Hypertension in Pregnancy

JF - Hypertension in Pregnancy

IS - 4

ER -

Maternal Serum Resistin Is Reduced in First Trimester Preeclampsia Pregnancies and Is a Marker of Clinical Severity

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater